UBS's Next Earnings Hurdle Sits Between a CHF 50 Target and a February Deadline

RBC Capital Markets has lifted its price target on UBS from CHF 44 to CHF 50 while keeping its "Outperform" rating, with analyst Anke Reingen arguing the Swiss lender is entering a phase where it can extract more from the framework it already has. The call, issued Friday, rests less on new promises than on whether UBS can convert existing conditions into repeatable earnings gains following the Credit Suisse integration.

That thesis now hinges on a single measure: return on CET1 capital. UBS reported a third-quarter 2026 net profit of USD 2.7 billion on October 28, alongside a reported RoCET1 of 14.8% and an underlying figure of 16.7%. For investors weighing Reingen's view, the reported number is the stricter yardstick — an improvement in the underlying metric alone would carry less weight if the headline return lags behind.

Cost Cuts Land Near the Finish Line

The earnings base Reingen is building on has been shaped by an aggressive efficiency drive. UBS disclosed cumulative gross cost savings of USD 13.2 billion through the end of September, and management expects close to USD 13.7 billion by the end of 2026 — a year-end figure that remains an internal projection rather than a delivered result.

Headcount has felt the squeeze. Bloomberg reported Thursday that UBS cut roughly 200 positions in London, hitting Wealth Management and Investment Banking among other areas. The reductions sit alongside the broader integration effort that has defined the bank since it absorbed its former rival.

Bern Holds the Other Half of the Equation

Capital rules remain the wild card in any return calculation, since the amount of equity UBS must hold feeds directly into RoCET1. A proposal in Switzerland's National Council could reduce the additional own-funds requirement UBS faces for its foreign subsidiaries, though media reports stress the potential impact is still unresolved. The National Council's economic affairs committee is due to debate the capital framework for UBS on November 23 and 24.

How that debate resolves matters for the optimistic case: if the reported return slips below expectations, the argument for a more profitable next phase loses conviction, and the capital question sharpens the scrutiny.

Takeover Chatter Cuts Both Ways

Speculation added a separate layer of noise on Thursday, when Wall St Engine claimed on X that Morgan Stanley could acquire UBS's foreign business for USD 138 billion, citing a 25% premium. Media coverage flagged the claim explicitly as speculation. Anyone factoring such a scenario into a position is tying its credibility to confirmation that may never arrive — whereas the operationally grounded case rests on what UBS earns on its own.

Disappointing results would put both the high return expectations and the speculative hopes under pressure at once, which is the serious counterargument to the bullish reading.

A Stake Trim and a Salary Signal

Elsewhere in the disclosure flow, UBS reported on November 2 that its stake in Bang & Olufsen had fallen below the 5% threshold, with 4.66% of shares and voting rights recorded. On Tuesday the bank also published its 2027 salary survey covering just under 400 Swiss companies, whose findings point to a restrained wage round despite brighter economic prospects.

February 3 Is the Reckoning

The next clearly scheduled test arrives on February 3, 2027, when UBS releases fourth-quarter 2026 figures. Until then, investors face a choice between two assumptions of differing rigor: confidence that the bank can make better operational use of its existing setup, or patience until further evidence lands. The first scenario holds if capital returns move in step with earnings; absent that proof, the second gains ground.